Literature DB >> 20861165

CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy.

Michael Baumann1, Mechthild Krause.   

Abstract

CD44, a cancer stem cell (CSC)-related surface marker, correlates with local control after radiotherapy of early laryngeal cancer. For the first time, a CSC-related marker has been functionally validated for radiotherapy in patients. CD44 expression bears the potential to predict the outcome of radiotherapy by assessment of CSC density. ©2010 AACR.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20861165     DOI： 10.1158/1078-0432.CCR-10-2244

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  33 in total

Review 1.  Head and neck cancer stem cells.

Authors:  S Krishnamurthy; J E Nör
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

2.  Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival.

Authors:  Anu Yadav; Annapurna Gupta; Neeraj Rastogi; Sushma Agrawal; Ashok Kumar; Vijay Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2015-08-30

3.  Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population.

Authors:  Kiran Lata Sharma; Anu Yadav; Annapurna Gupta; Sonam Tulsayan; Vijay Kumar; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2013-11-05

4.  In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.

Authors:  Nidaa Ababneh; Walhan Alshaer; Omar Allozi; Azmi Mahafzah; Mohammed El-Khateeb; Hervé Hillaireau; Magali Noiray; Elias Fattal; Said Ismail
Journal:  Nucleic Acid Ther       Date:  2013-10-30       Impact factor: 5.486

Review 5.  [Cancer stem cells and high-throughput screening methods].

Authors:  A Dubrovska; A Abdollahi; I Tinhofer
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

Review 6.  Individualization of cancer treatment from radiotherapy perspective.

Authors:  Ala Yaromina; Mechthild Krause; Michael Baumann
Journal:  Mol Oncol       Date:  2012-02-09       Impact factor: 6.603

Review 7.  The changing paradigm of tumour response to irradiation.

Authors:  Richard P Hill
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

Review 8.  Cancer stem cell marker glycosylation: Nature, function and significance.

Authors:  Brody W Mallard; Joe Tiralongo
Journal:  Glycoconj J       Date:  2017-06-17       Impact factor: 2.916

Review 9.  Lab-on-a-chip electrical multiplexing techniques for cellular and molecular biomarker detection.

Authors:  Fan Liu; Liwei Ni; Jiang Zhe
Journal:  Biomicrofluidics       Date:  2018-04-10       Impact factor: 2.800

Review 10.  Perivascular stem cell niche in head and neck cancer.

Authors:  Kathryn E Ritchie; Jacques E Nör
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.